News & Events

Added to My Toolbox
Removed from My Toolbox
Added to My Toolbox
Removed from My Toolbox
Jan 28, 2015

Study Disputes Use of Blood Thinners in Younger AFib Patients

The risks associated with blood thinners may outweigh the benefits in younger atrial fibrillation patients with low stroke risk.

The risks associated with blood thinners may outweigh the benefits in younger atrial fibrillation (AFib) patients at low risk of stroke, according to a study published in the Journal of the American College of Cardiology.

Generally speaking, nearly all patients with atrial fibrillation—the most common type of abnormal heart rhythm—can benefit from blood thinners. Atrial fibrillation greatly increases risk of stroke. Blood thinners, which prevent blood clots, can greatly reduce that risk. However, blood thinners aren’t appropriate for all AFib patients.

According to guidelines from the American College of Cardiology, American Heart Association and Heart Rhythm Society, only patients at increased risk for stroke should take blood thinners, given the risk of complications associated with this type of drug. Physicians are able to determine stroke risk using the CHA2DS2-VASc score, which takes into account various cardiovascular risk factors, such as age and diabetes. Based on this score, patients with a risk score greater than 1 should take blood thinners, and it’s estimated that 85% of all patients with atrial fibrillation fall into this category.

However, researchers recently analyzed a national Swedish registry to determine whether all patients with a risk score of 1 should qualify for blood thinners. The registry included more than 140,000 patients with atrial fibrillation that never took blood thinners for their condition. Researchers compared the risk score among participants, tracking outcomes for up to five years, and found that stroke risk varied greatly among patients with a risk score of 1. Overall, stroke risk was lower than expected among patients with a risk score of 1, particularly for patients younger than 65 years of age.

Based on findings, authors believe that the risks associated with blood thinner use may outweigh the benefits in younger AFib patients at very low risk for stroke. However, few clinical trials have tested blood thinner use in low-risk AFib patients, and experts argue for further research on the issue. In general, blood thinners are beneficial for most AFib patients. But as experts emphasize, it’s important to prevent both over- and underuse of such treatment to provide the greatest net benefit to patients.

Read the full study in the Journal of the American College of Cardiology.

Questions for You to Consider

  • What is atrial fibrillation?

  • Atrial fibrillation is an irregular heart rhythm caused by abnormal, chaotic electrical impulses in the heart’s upper chambers, the atria. These electrical impulses, which interfere with the heart’s natural pacemaker, fire so rapidly the atria cannot beat with a regular rhythm or squeeze out blood effectively. Instead, they merely quiver while the ventricles, the heart’s lower chambers, beat rapidly.

Featured Video

Dr. Kanny S. Grewal, FACC, presents at a Living with Atrial Fibrillation event in Columbus, Ohio in Oct. 2014.

Related

AFib Treatment Changes Over Time as Stroke Risk Increases

Patients with an irregular heart rhythm should revisit treatment options regularly, study suggests.

Study Highlights the Need to Improve Education on Atrial Fibrillation

Study participants’ levels of education were closely related to their AFib treatment decisions.

One-Third of Atrial Fibrillation Patients Not Getting Optimal Treatment

Study finds one in three AFib patients are not receiving recommended blood thinners to reduce risk of stroke.

Sex Differences in Blood Thinner Treatment for AFib

Despite the drug’s benefits, women are less likely to receive optimal dose of dabigatran.

New Drugs Offer Better Treatment Options for Patients with AFib and Liver Disease

Study confirms safety and efficacy of new drugs in liver patients with an abnormal heart rhythm.

Questions about a drug?